Top

Published in:

Open Access 01-10-2008 | Review Article

Serotonin and migraine: a reconsideration of the central theory

Author: Alessandro Panconesi

Published in: The Journal of Headache and Pain | Issue 5/2008

Abstract

The 5-hydroxytryptamine (5-HT) has been implicated in migraine pathophysiology for the past 50 years. A low central 5-HT disposition associated with an increase in 5-HT release during attack is the most convincing change of 5-HT metabolism implicated in migraine. Peripheral studies on plasma/platelet have not generally shown low 5-HT levels. Studies on 5-HT reactivity showed hypersensitivity, also expressed as reduced tachyphylaxis (habituation), which successively was evidenced as the most characteristic marker of an altered sensory neurotransmission. Even the gender and seasonal variations of 5-HT parameters seem to agree with a low 5-HT turnover with receptoral hypersensitivity. The interpretation of the effects of some serotonergic drugs and recent neuroimaging studies give major evidence for this cascade of events. Although the exact mechanism that links abnormal 5-HT neurotransmission to the manifestation of head pain has yet to be fully understood, a deficit on 5-HT descending pain inhibitory system is still probably today the most implicated in migraine pathophysiology. This short review focuses and discusses the alteration of peripheral and central 5-HT parameters in migraine patients.

Panconesi A (1995) 5-Hydroxytryptamine parameters in the periphery: how useful are they in the study of headaches? J Serotonin Res 2:117–137

Sicuteri F, Testi A, Anselmi B (1961) Biochemical investigations in headache: increase in the hydroxyndoleacetic acid excretion during migraine attacks. Int Arch Allergy Appl Immunol 19:55–58, 1:CAS:528:DyaF38XhsV2kuw%3D%3DCrossRef

Sicuteri F (1972) Headache as possible expression of deficiency of brain 5-hydroxytryptamine (central denervation supersensitivity). Headache 12:69–72, 4262476, 1:STN:280:DyaE383mslGqtw%3D%3D, 10.1111/j.1526-4610.1972.hed1202069.xPubMedCrossRef

Sicuteri F (1976) Hypothesis: migraine, a central biochemical dysnociception. Headache 16:145–159, 184065, 1:CAS:528:DyaE28XlslGjtr4%3D, 10.1111/j.1526-4610.1976.hed1604145.xPubMedCrossRef

Jans LAW, Riedel WJ, Markus CR, Blokland A (2007) Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry 12:522–543, 17160067, 1:CAS:528:DC%2BD2sXls1Kjur4%3D, 10.1038/sj.mp.4001920PubMedCrossRef

Panconesi A, Sicuteri R (1997) Headache induced by serotonergic agonists––a key to the interpretation of migraine pathogenesis? Cephalalgia 17:3–14, 9051329, 1:STN:280:DyaK2s3gtlOmtQ%3D%3D, 10.1046/j.1468-2982.1997.1701003.xPubMedCrossRef

Hamel E (2007) Serotonin and migraine: biology and clinical implications. Cephalalgia 27:1295–1300, 10.1111/j.1468-2982.2007.01476.xCrossRef

Montagna P (2008) The primary headaches: genetics, epigenetics and behavioural genetic model. J Headache Pain 9:57–69, 18345478, 10.1007/s10194-008-0026-xPubMedCentralPubMedCrossRef

Uebelhack R, Franke L, Herold N, Plotkin M, Amthauer H, Felix R (2006) Brain and platelet serotonin transporter in humans––correlation between [123I]-ADAM SPECT and serotonergic measurements in platelets. Neurosci Lett 406:153–158, 16934400, 1:CAS:528:DC%2BD28XpsVOnu7w%3D, 10.1016/j.neulet.2006.06.004PubMedCrossRef

10.

Ferrari MD, Saxena PR (1993) On serotonin and migraine: a clinical and pharmacological review. Cephalalgia 13:151–165, 8395342, 1:STN:280:DyaK3szmsV2mtQ%3D%3D, 10.1046/j.1468-2982.1993.1303151.xPubMedCrossRef

11.

Waldenlinden E, Ross SB, Saaf J, Ekbom K, Wetterberg L (1985) Concentration and uptake of 5-hydroxytryptamine in platelets from cluster headache and migraine patients. Cephalalgia 5:45–54, 10.1046/j.1468-2982.1985.0501045.xCrossRef

12.

Shukla R, Shanker K, Nag D, Verma M, Bhargava KP (1987) Serotonin in tension headache. J Neurol Neurosurg Psychiatry 50:1682–1684, 3437303, 1:STN:280:DyaL1c7ktVyisQ%3D%3DPubMedCentralPubMedCrossRef

13.

Takeshima T, Shimomura T, Takahashi K (1987) Platelet activation in muscle contraction headache and migraine. Cephalalgia 7:239–243, 2962739, 1:STN:280:DyaL1c7gvFGjtA%3D%3D, 10.1046/j.1468-2982.1987.0704239.xPubMedCrossRef

14.

Anthony M, Lance JW (1989) Plasma serotonin in patients with chronic tension headaches. J Neurol Neurosurg Psychiatry 52:182–184, 2703837, 1:STN:280:DyaL1M7pvV2quw%3D%3DPubMedCentralPubMedCrossRef

15.

Ferrari MD, Odink J, Tapparelli C, Van Kempen GMJ, Pennings EJM, Bruyn GW (1989) Serotonin metabolism in migraine. Neurology 39:1239–1242, 2475821, 1:STN:280:DyaL1MzmsFKjuw%3D%3DPubMedCrossRef

16.

Nakano T, Shimomura T, Takahashi K, Ikawa S (1993) Platelet substance P and 5-hydroxytryptamine in migraine and tension-type headache. Headache 33:528–532, 7507472, 1:STN:280:DyaK2c7isVagtw%3D%3D, 10.1111/j.1526-4610.1993.hed3310528.xPubMedCrossRef

17.

D’Andrea G, Hasselmark L, Alecci M, Cananzi A, Perini F, Welch KM (1994) Platelet secretion from dense and alpha-granules in vitro in migraine with or without aura. J Neurol Neurosurg Psychiatry 57:557–561, 8201323, 1:STN:280:ByuB28%2FitVI%3DPubMedCentralPubMedCrossRef

18.

D’Andrea G, Cananzi AR, Perini F, Hasselmark L (1995) Platelets models and their possible usefulness in the study of migraine pathogenesis. Cephalalgia 15:265–271, 7585921, 1:STN:280:BymD383ktVc%3D, 10.1046/j.1468-2982.1995.1504265.xPubMedCrossRef

19.

Kitano A, Shimomura T, Takeshima T, Takahashi K (1994) Increased 11-dehydrothromboxane B2 in migraine: platelet hyperfunction in patients with migraine during headache-free period. Headache 34:515–518, 8002323, 1:STN:280:DyaK2M%2FpsFKhtQ%3D%3D, 10.1111/j.1526-4610.1994.hed3409515.xPubMedCrossRef

20.

Srikiatkhachorn A, Anthony M (1996) Platelet serotonin in patients with analgesic-induced headache. Cephalalgia 16:423–426, 8902251, 1:STN:280:DyaK2s%2Flsl2hsw%3D%3D, 10.1046/j.1468-2982.1996.1606423.xPubMedCrossRef

21.

Stronks DL, Tulen JH, Verheij R, Boomsma F, Fekkes D, Pepplinkhuizen L, Mantel GW, Passchier J (1998) Serotonergic, cathecolaminergic, and cardiovascular reactions to mental stress in female migraine patients. A controlled study. Headache 38:270–280, 9595866, 1:STN:280:DyaK1c3lvVagsg%3D%3D, 10.1046/j.1526-4610.1998.3804270.xPubMedCrossRef

22.

Evers S, Quibeldey F, Grotemeyer K-H, Suhr B, Husstedt I-W (1999) Dynamic changes of cognitive habituation and serotonin metabolism during the migraine interval. Cephalalgia 19:485–491, 10403063, 1:STN:280:DyaK1MzjtFCqtw%3D%3D, 10.1046/j.1468-2982.1999.019005485.xPubMedCrossRef

23.

Jerney B, Vladic A, Cicin-Sain L, Hranilovic D, Banovic M, Balija M, Bilic E, Sucic Z, Vukadin S, Grgicevic D (2002) Platelet serotonin measures in migraine. Headache 42:588–595, 10.1046/j.1526-4610.2002.02145.xCrossRef

24.

Juhasz G, Zsombok T, Laszik A, Jakus R, Faludi G, Sotonyi P, Bagdy G (2003) Despite the general correlation of the serotonin transporter gene regulatory region polymorphism (5-HTTLPR) and platelet serotonin concentration, lower platelet serotonin concentration in migraine patients is independent of the 5-HTTLPR variants. Neurosci Lett 350:56–60, 12962916, 1:CAS:528:DC%2BD3sXmvVyiur8%3D, 10.1016/S0304-3940(03)00834-6PubMedCrossRef

25.

Drummond PD (2005) Effect of tryptophan depletion on symptoms of motion sickness in migraineurs. Neurology 65:620–622, 16116130, 1:CAS:528:DC%2BD2MXntFGnu74%3D, 10.1212/01.wnl.0000172339.15577.a6PubMedCrossRef

26.

Bendtsen L, Mellerup ET (1998) The platelet serotonin transporter in primary headaches. Eur J Neurol 5:277–282, 10210842, 10.1046/j.1468-1331.1998.530277.xPubMedCrossRef

27.

Juhasz G, Zsombok T, Modos EA, Olajos S, Jakab B, Nemeth J, Szolcsanyi J, Vitrai J, Bagdy G (2003) NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 106:461–470, 14659530, 1:CAS:528:DC%2BD3sXptlyjs7k%3D, 10.1016/j.pain.2003.09.008PubMedCrossRef

28.

Rolf LH, Wiele G, Brune GG (1981) 5-Hydroxytryptamine in platelets of patients with muscle contraction headache. Headache 21:10–11, 7461964, 1:STN:280:DyaL3M7hs1KitQ%3D%3D, 10.1111/j.1526-4610.1981.hed2101010.xPubMedCrossRef

29.

Shimomura T, Takahashi K (1990) Alteration of platelet serotonin in patients with chronic tension-type headache during cold pressor test. Headache 30:581–583, 2262311, 1:STN:280:DyaK3M%2Fos1Slsw%3D%3D, 10.1111/j.1526-4610.1990.hed3009581.xPubMedCrossRef

30.

Leira R, Castillo J, Martinez F, Prieto JM, Noya M (1993) Platelet-rich plasma serotonin levels in tension-type headache and depression. Cephalalgia 13:346–348, 8242728, 1:STN:280:DyaK2c%2FmtF2luw%3D%3D, 10.1046/j.1468-2982.1993.1305346.xPubMedCrossRef

31.

Jensen R, Hindberg I (1994) Plasma serotonin increase during episodes of tension-type headache. Cephalalgia 14:219–222, 7954743, 1:STN:280:DyaK2M%2Fkt1Kluw%3D%3D, 10.1046/j.1468-2982.1994.014003219.xPubMedCrossRef

32.

D’Andrea G, Hasselmark L, Cananzi AR, Alecci M, Perini F, Zamberlan F, Welch KMA (1995) Metabolism and menstrual cycle rhythmicity of serotonin in primary headache. Headache 35:216–221, 7539781, 1:STN:280:ByqB1Mzms1U%3D, 10.1111/j.1526-4610.1995.hed3504216.xPubMedCrossRef

33.

Mazzotta G, Sarchielli P, Gaggioli A, Gallai V (1997) Study of pressure pain and cellular concentration of neurotransmitters related to nociception in episodic tension-type headache patients. Headache 37:565–571, 9385755, 1:STN:280:DyaK1c%2Fks1yltw%3D%3D, 10.1046/j.1526-4610.1997.3709565.xPubMedCrossRef

34.

Bendtsen L, Jensen R, Hindberg I, Gammeltoft S, Olesen J (1997) Serotonin metabolism in chronic tension-type headache. Cephalalgia 17:843–848, 9453272, 1:STN:280:DyaK1c7hsVSitQ%3D%3D, 10.1046/j.1468-2982.1997.1708843.xPubMedCrossRef

35.

Sarchielli P, Alberti A, Russo S, Codini M, Panico R, Floridi A, Gallai V (1999) Nitric oxide pathway, Ca²⁺, and serotonin content in platelets from patients suffering from chronic daily headache. Cephalalgia 19:810–816, 10595291, 1:STN:280:DC%2BD3c%2FmtFKltA%3D%3D, 10.1046/j.1468-2982.1999.1909810.xPubMedCrossRef

36.

Rossi C, Pini LA, Cupini ML, Calabresi P, Sarchielli P (2008) Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. Eur J Clin Pharmacol 64:1–8, 18004553, 1:CAS:528:DC%2BD1cXjsFygsw%3D%3D, 10.1007/s00228-007-0391-4PubMedCrossRef

37.

Panconesi A, Anselmi B, Curradi C, Del Bianco PL, Franchi G, Sicuteri F, Tarquini B (1986) Biological rhythms of vascular reactivity to serotonin in man. In: Halberg F, Reale L, Tarquini B (eds) Proceedings of the II international symposium on chronobiologic approach to social medicine. Istituto Italiano di Medicina Sociale, Rome, pp 701–714

38.

Dignan RJ, Yeh T Jr, Dike CM, Lutz HAIII, Wechsler AS (1992) The influence of age and sex on human internal mammary artery size and reactivity. Ann Thorac Surg 53:792–797, 1570972, 1:STN:280:DyaK383jvVOgtw%3D%3DPubMedCrossRef

39.

Mong K, Duggan JA, Tabrizchi R (2002) Comparative study of functional responses and morphometric state of distal radial arteries in male and female. Ann Thorac Surg 74:2126–2131, 12643406, 10.1016/S0003-4975(02)03984-XPubMedCrossRef

40.

Weiss LA, Abney M, Cook EH Jr, Ober C (2005) Sex-specific genetic architecture of blood serotonin levels. Am J Hum Genet 76:33–41, 15526234, 1:CAS:528:DC%2BD2MXhtVyntA%3D%3D, 10.1086/426697PubMedCentralPubMedCrossRef

41.

Cosgrove KP, Mazure CM, Staley JK (2007) Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry 62:847–855, 17544382, 1:CAS:528:DC%2BD2sXhtFerurzL, 10.1016/j.biopsych.2007.03.001PubMedCentralPubMedCrossRef

42.

Sakai Y, Nishikawa M, Leyton M, Benkelfat C, Young SN, Diksic M (2006) Cortical trapping of α-[¹¹C]methyl-l-tryptophan, an index of serotonin synthesis, is lower in females than males. NeuroImage 33:815–824, 16996279, 1:STN:280:DC%2BD28nmvVWrtw%3D%3D, 10.1016/j.neuroimage.2006.08.004PubMedCrossRef

43.

Heninger GR (1997) Serotonin, sex, and psychiatric illness. Proc Natl Acad Sci 94:4823–4824, 9144148, 1:CAS:528:DyaK2sXjtlaltrs%3D, 10.1073/pnas.94.10.4823PubMedCentralPubMedCrossRef

44.

Nishizava S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, Blier P, Diksic M (1997) Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci 94:5308–5313, 10.1073/pnas.94.10.5308CrossRef

45.

Chugani DC, Muzik O, Chakraborty P, Magner T, Chugani HT (1998) Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-l-tryptophan. Synapse 28:33–43, 9414016, 1:CAS:528:DyaK2sXns1Kmtrs%3D, 10.1002/(SICI)1098-2396(199801)28:1<33::AID-SYN5>3.0.CO;2-DPubMedCrossRef

46.

Centeno ML, Reddy AP, Smith LJ, Sanchez RL, Henderson JA, Salli NC, Hess DJ, Pau FKY, Bethea CL (2007) Serotonin in microdialysate from mediobasal hypothalamus increases after progesterone administration to estrogen primed macaques. Eur J Pharmacol 555:67–75, 17112509, 1:CAS:528:DC%2BD2sXhsFKgsw%3D%3D, 10.1016/j.ejphar.2006.10.027PubMedCentralPubMedCrossRef

47.

Marrelli A, Marini C, Prencipe M (1988) Seasonal and meteorological factors in primary headaches. Headache 28:111–113, 3372236, 1:STN:280:DyaL1c3isleqsw%3D%3D, 10.1111/j.1526-4610.1988.hed2802111.xPubMedCrossRef

48.

Cugini P, Romit A, Di Palma L, Giacovazzo M (1990) Common migraine as a weekly and seasonal headache. Chronobiol Int 7:467–469, 2097080, 1:STN:280:DyaK3M3ms1egsg%3D%3D, 10.3109/07420529009059158PubMedCrossRef

49.

Robbins L (1994) Precipitating factors in migraine: a retrospective review of 494 patients. Headache 34:214–216, 8014037, 1:STN:280:DyaK2c3osVSktQ%3D%3D, 10.1111/j.1526-4610.1994.hed3404214.xPubMedCrossRef

50.

Fox AW, Davis RL (1998) Migraine chronobiology. Headache 38:436–441, 9664747, 1:STN:280:DyaK1czivFCnuw%3D%3D, 10.1046/j.1526-4610.1998.3806436.xPubMedCrossRef

51.

Rieder A, Lobentanz I, Zeitlhofer J, Mitsche N, Lawrence K, Schwarz B, Kunze M (2004) Background morbidity of headache in an adult general population. Results of the Austrian SERMO (self-reported morbidity) study. Wien Klin Wochenschr 116:176–181, 15088992PubMedCrossRef

52.

Soriani S, Fiumana E, Manfredini R, Boari B, Battistella PA, Canetta E, Pedretti S, Borgna-Pignatti C (2006) Circadian and seasonal variation of migraine attacks in children. Headache 46:1571–1574, 17115990, 10.1111/j.1526-4610.2006.00613.xPubMedCrossRef

53.

Alstadhaug KB, Bekkelund S, Salvesen R (2007) Circannual periodicity of migraine? Eur J Neurol 14:983–988, 17718689, 1:STN:280:DC%2BD2srgtVKqtw%3D%3D, 10.1111/j.1468-1331.2007.01828.xPubMedCrossRef

54.

Brewerton TD (1989) Seasonal variation of serotonin function in humans: research and clinical implications. Ann Clin Psychiatry 1:153–164, 10.3109/10401238909149974CrossRef

55.

Lambert GW, Reid C, Kaye DM, Jennings GL, Esler MD (2002) Effect of sunlight and season on serotonin turnover in the brain. Lancet 360:1840–1842, 12480364, 1:CAS:528:DC%2BD38Xpt12mtrw%3D, 10.1016/S0140-6736(02)11737-5PubMedCrossRef

56.

Neumeister A, Pirker W, Willeit M, Praschak-Rieder N, Asenbaum S, Brucke T, Kasper S (2000) Seasonal variation in availability of serotonin transporter binding sites in healthy female subjects as measured by [¹²³I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psichiatry 47:158–160, 1:CAS:528:DC%2BD3cXosVagug%3D%3D, 10.1016/S0006-3223(99)00241-3CrossRef

57.

Sicuteri F, Panconesi A, Franchi G, Del Bianco PL, Anselmi B (1983) Impaired 5-hydroxytryptamine tachyphylaxis in migraine. Cephalalgia 3:139–142, 6313199, 1:STN:280:DyaL2c%2Fis1CntA%3D%3D, 10.1046/j.1468-2982.1983.0303139.xPubMedCrossRef

58.

Hegerl U, Juckel G (1993) Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatr 33:173–187, 1:STN:280:DyaK3s7pt1Ciug%3D%3D, 10.1016/0006-3223(93)90137-3CrossRef

59.

Ambrosini A, de Noordhout AM, Sandor PS, Schoenen J (2003) Electrophysiological studies in migraine: a comprehensive review of their interest and limitations. Cephalalgia 23(Suppl 1):13–31, 12699456, 10.1046/j.1468-2982.2003.00571.xPubMedCrossRef

60.

Ambrosini A, Rossi P, De Pasqua V, Pierelli F, Schoenen J (2003) Lack of habituation causes high intensity dependance of auditory evoked cortical potentials in migraine. Brain 126:2009–2015, 12821515, 1:STN:280:DC%2BD3szpslyjtQ%3D%3D, 10.1093/brain/awg206PubMedCrossRef

61.

Magis D, Ambrosini A, Bendtsen L, Ertas M, Kaube H, Schoenen J (EUROHEAD project) (2007) Evaluation and proposal for optimalization of neurophysiological tests in migraine: part 1-electrophysiological tests. Cephalalgia 27:1323–1338, 17970766, 1:STN:280:DC%2BD2snpsFWjsQ%3D%3D, 10.1111/j.1468-2982.2007.01440.xPubMedCrossRef

62.

Coppola G, Ambrosini A, Di Clemente L, Magis D, Fumal A, Gerard P, Pierelli F, Schoenen J (2007) Interictal abnormalities of gamma band activity in visual evoked responses in migraine: an indication of thalamocortical dysrhythmia? Cephalalgia 27:1360–1367, 17986271, 1:STN:280:DC%2BD2snpsFalsg%3D%3D, 10.1111/j.1468-2982.2007.01466.xPubMedCrossRef

63.

Judit A, Sandor PS, Schoenen J (2000) Habituation of visual and intensity dependence of auditory evoked cortical potentials tends to normalize just before and during the migraine attack. Cephalalgia 20:714–719, 11167900, 1:STN:280:DC%2BD3M7nvFantQ%3D%3D, 10.1046/j.1468-2982.2000.00122.xPubMedCrossRef

64.

Kropp P, Gerber W-D (1995) Contingent negative variation during migraine attack and interval: evidence for normalization of slow cortical potentials during the attack. Cephalalgia 15:123–128, 7641246, 1:STN:280:DyaK2MzmvVKqsw%3D%3D, 10.1046/j.1468-2982.1995.015002123.xPubMedCrossRef

65.

Sicuteri F, Poggioni M, Panconesi A (1990) Upregulation of pain transmission from deficient serotonergic analgesia in migraine. In: Paoletti R, Vanhoutte PM, Brunello N, Maggi FM (eds) Serotonin: from cell biology to pharmacology and therapeutics. Kluwer, Dordrecht, pp 391–404CrossRef

66.

Huber D, Henrich G, Gundel H (2005) Psychophysiological response patterns of migraine patients in two habituation tests. Headache 45:1375–1387, 16324170, 10.1111/j.1526-4610.2005.00270.xPubMedCrossRef

67.

Ozkul Y, Ay H (2007) Habituation of sympathetic skin response in migraine and tension type headache. Auton Neurosci 134:81–84, 17395550, 10.1016/j.autneu.2007.02.006PubMedCrossRef

68.

Iversen HK, Olesen J (1993) Experimental headache. In: Olesen J, Tfelt-Hansen P, Welch KMA (eds) The headaches. Raven Press, New York, pp 145–151

69.

Del Bene E, Anselmi B, Del Bianco PL, Fanciullacci M, Galli P, Salmon S, Sicuteri F (1997) Fenfluramine headache: a biochemical and monoamine receptorial human study. In: Sicuteri F (ed) Headache: new vistas. Biomedical Press, Florence, pp 101–109

70.

Sicuteri F (1971) Pain syndrome in man following treatment with p-chlorophenylalanine. Pharmacol Res Comm 3:401–407, 1:CAS:528:DyaE38XkslSgtbs%3D, 10.1016/0031-6989(71)90012-9CrossRef

71.

Nattero G, Lisino F, Brandi G, Gastaldi L (1976) Reserpine in the prevention of migraine and in the therapy of tension-vascular headache. Minerva Med 67:1871–1875, 934534, 1:STN:280:DyaE283itV2htA%3D%3DPubMed

72.

Muldoon MF, Manuck SB, Jansma CL, Moore AL, Perel J, Mann JJ (1996) D, L-Fenfluramine challenge test: experience in nonpatient sample. Biol Psychiatry 39:761–768, 8731516, 1:CAS:528:DyaK28XjtVGks7o%3D, 10.1016/0006-3223(95)00227-8PubMedCrossRef

73.

Brewerton TD, Murphy DL, Mueller EA, Jimerson DC (1988) Induction of migraine-like headaches by the serotonin agonist m-chlorophenylpiperazine. Clin Pharmacol Ther 43:605–609, 3378382, 1:CAS:528:DyaL1cXkvVKksbg%3DPubMedCrossRef

74.

Brewerton TD, Murphy DL, Lesem MD, Brandt HA, Jimerson DC (1992) Headache responses following m-chlorophenylpiperazine in bulimics and controls. Headache 32:217–222, 1628957, 1:STN:280:DyaK38zjt1WltA%3D%3D, 10.1111/j.1526-4610.1992.hed3205217.xPubMedCrossRef

75.

Gordon ML, Lipton RB, Brown S-L, Nakraseive C, Russell M, Pollack SZ, Korn ML, Merriam A, Solomon S, van Praag HM (1993) Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated. Cephalalgia 13:400–405, 8313453, 1:STN:280:DyaK2c7kslCrug%3D%3D, 10.1046/j.1468-2982.1993.1306400.xPubMedCrossRef

76.

Gijsman HJ, van Gerven JMA, Tieleman MC, Schoemaker RC, Pieters MSM, Ferrari MD, Cohen AF, van Kempen GMJ (1988) Pharmacokinetic and pharmacodynamic profile of oral and intravenous meta-chlorophenylpiperazine in healthy volunteers. J Clin Psychopharmacol 18:289–295, 10.1097/00004714-199808000-00007CrossRef

77.

Leone M, Attanasio A, Croci D, Filippini G, D’Amico D, Grazzi L, Nespolo A, Bussone G (2000) The serotonergic agent m-chlorophenylpiperazine induces migraine attacks: a controlled study. Neurology 55:136–139, 10891925, 1:CAS:528:DC%2BD3cXlsVCgsrw%3DPubMedCrossRef

78.

Feuchtl A, Bagli M, Stephan R, Frahnert C, Kolsch H, Kuhn K-U, Rao ML (2004) Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile. Pharmacopsychiatry 37:180–188, 15467976, 1:CAS:528:DC%2BD2cXmslWkt7o%3D, 10.1055/s-2004-827175PubMedCrossRef

79.

Leone M, Attanasio A, Croci D, Ferraris A, D’Amico D, Grazzi L, Nespolo MA, Bussone G (1988) 5-HT^1A receptor hypersensitivity in migraine is suggested by the m-chlorophenylpiperazine test. Neuroreport 9:2605–2608, 10.1097/00001756-199808030-00033CrossRef

80.

Rothman RB, Baumann MH (2002) Serotonin re leasing agents. Neurochemical, therapeutic and adverse effects. Pharmacol Biochem Behav 71:825–836, 11888573, 1:CAS:528:DC%2BD38XhvVChu7Y%3D, 10.1016/S0091-3057(01)00669-4PubMedCrossRef

81.

Baylen CA, Rosemberg H (2006) A review of the acute subjective effects of MDMA/ectasy. Addiction 101:933–947, 16771886, 10.1111/j.1360-0443.2006.01423.xPubMedCrossRef

82.

Moja PL, Cusi C, Sterzi RR, Canepari C (2007) Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headache. The Cochrane Library 4:1–50

83.

Tomkins GE, Jackson JL, O’Malley PG, Balden E, Santoro JE (2001) Treatment of chronic headache with antidepressant: a meta-analysis. Am J Med 111:54–63, 11448661, 1:CAS:528:DC%2BD3MXltVegs78%3D, 10.1016/S0002-9343(01)00762-8PubMedCrossRef

84.

Ashina S, Bendtsen L, Jensen R (2004) Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition. Pain 108:108–114, 15109513, 1:CAS:528:DC%2BD2cXhsVKhtLg%3D, 10.1016/j.pain.2003.12.012PubMedCrossRef

85.

Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157–203, 7938165, 1:CAS:528:DyaK2cXlslSlsb0%3DPubMed

86.

Moore P, Landolt H-P, Seifritz E, Clark C, Bhatti T, Kelsoe J, Rapaport M, Gillin JC (2000) Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology 23:601–622, 11063917, 1:CAS:528:DC%2BD3cXosFWltr4%3D, 10.1016/S0893-133X(00)00161-5PubMedCrossRef

87.

Van der Plasse G, Meerkerk DJ, Lieben CKJ, Blokland A, Feenstra MGP (2007) Lack of evidence for reduced prefrontal cortical serotonin and dopamine efflux after acute tryptophan depletion. Psychopharmacology 195:377–385, 17713760, 1:CAS:528:DC%2BD2sXhtlWktbzL, 10.1007/s00213-007-0908-7PubMedCentralPubMedCrossRef

88.

Fusar-Poli P, Allen P, McGuire P, Placentino A, Cortesi M, Perez J (2006) Neuroimaging and electrophysiological studies of the effects of acute tryptophan depletion: a systematic review of the literature. Psychopharmacology 188:131–143, 16915379, 1:CAS:528:DC%2BD28Xpt1OntLg%3D, 10.1007/s00213-006-0493-1PubMedCrossRef

89.

Drummond PD (2006) Tryptophan depletion increases nausea, headache and photophobia in migraine sufferers. Cephalalgia 26:1225–1233, 16961791, 1:STN:280:DC%2BD28rjs12isg%3D%3D, 10.1111/j.1468-2982.2006.01212.xPubMedCrossRef

90.

Schuh-Hofer S, Richter M, Geworski L, Villringer A, Israel H, Wenzel R, Munz DL, Arnold G (2007) Increased serotonin transporter availability in the brainstem of migraineurs. J Neurol 254:789–796, 17351723, 1:CAS:528:DC%2BD2sXovFait70%3D, 10.1007/s00415-006-0444-0PubMedCrossRef

91.

Chugani DC, Niimura K, Chaturvedi S, Muzik O, Fakkouri M, Lee ML, Chugani HT (1999) Increased brain serotonin synthesis in migraine. Neurology 53:1473–1479, 10534254, 1:CAS:528:DyaK1MXntlWhu7k%3DPubMedCrossRef

92.

Sakai Y, Dobson C, Diksic M, Aubè M, Hamel E (2008) Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis. Neurology 70:431–439, 18250288, 1:CAS:528:DC%2BD1cXhtFels7o%3D, 10.1212/01.wnl.0000299095.65331.6fPubMedCrossRef

93.

Diksic M, Sakai Y, Nishikawa M, Hamel E, Aubé M (2008) Female migraine patients exhibit lower brain serotonin (5-HT) synthesis interictally than female controls. Cephalalgia 28:440 (abstract), (abstract)

94.

Yoshimura M, Furue H (2006) Mechanisms for the anti-nociceptive actions of the descending noradrenergic and serotonergic systems in the spinal cord. J Pharmacol Sci 101:107–117, 16766858, 1:CAS:528:DC%2BD28XmslWrsb4%3D, 10.1254/jphs.CRJ06008XPubMedCrossRef

95.

Sommer C (2006) Is serotonin hyperalgesic or analgesic? Curr Pain Head Rep 10:101–106, 10.1007/s11916-006-0020-4CrossRef

96.

Hamel E (2006) Perivascular nerves and the regulation of cerebrovascular tone. J Appl Physiol 100:1059–1065, 16467392, 10.1152/japplphysiol.00954.2005PubMedCrossRef

97.

Strassman AM, Levy D (2006) Response properties of dural nociceptors in relation to headache. J Neurophysiol 95:1298–1306, 16492942, 10.1152/jn.01293.2005PubMedCrossRef

98.

LeMarquand D, Pihl RO, Benkelfat C (1994) Serotonin and alcohol intake, abuse, and dependence: findings of animal studies. Biol Psichiatry 36:395–421, 1:CAS:528:DyaK2cXmsleqs70%3D, 10.1016/0006-3223(94)91215-7CrossRef

99.

Panconesi A (2008) Alcohol and migraine: trigger factor, consumption, mechanisms. A review. J Headache Pain 9:71–76, 18317865, 10.1007/s10194-008-0020-3PubMedCentralPubMedCrossRef

100.

Flugge G, van Kampen M, Mijnster MJ (2004) Perturbations in brain monoamine systems during stress. Cell Tissue Res 315:1–14, 14579145, 10.1007/s00441-003-0807-0, 1:CAS:528:DC%2BD3sXpslChurc%3DPubMedCrossRef

101.

Sicuteri F (1987) Quasi-phantom head pain from functional deafferentation. Clin J Pain 3:63–80, 10.1097/00002508-198703020-00001CrossRef

102.

Lance JW, Goadsby PJ (2005) Mechanism and management of Headache, 7th edn. Elsevier, New York

103.

Burnstein R, Jakubowski M, Levy D (2005) Anti-migraine. action of triptans is preceded by transient aggravation of headache caused by activation of meningeal nociceptors. Pain 115:21–22, 10.1016/j.pain.2005.01.027, 1:CAS:528:DC%2BD2MXjt1Squr4%3DCrossRef

104.

Panconesi A (1994) Azione vasocostrittiva del sumatriptan nei vasi periferici dell’uomo. Confin Cephalal 3:5–12

105.

Panconesi A, Franchi G, Anselmi B, Curradi C, Tarquini B (1993) Amplifying effect of sumatriptan on noradrenaline venoconstriction in migraine patients. Cephalalgia 13:383–388, 8313451, 1:STN:280:DyaK2c7kslCrtw%3D%3D, 10.1046/j.1468-2982.1993.1306383.xPubMedCrossRef

106.

Panconesi A, Franchi G, Anselmi B, Curradi C (1994) On the mechanism of sumatriptan side effects. In: Fusco BM, Giacovazzo M (eds) Unilateral headache: focus on recent advances. RD Editori, Rome, pp 111–116

107.

Potrebic S, Ahn AH, Skinner K, Fields HL, Basbaum AI (2003) Peptidergic nociceptors of both trigeminal and dorsal root ganglia express serotonin 1D receptors: implications for the selective antimigraine action of triptans. J Neurosci 23:10988–10997, 14645495, 1:CAS:528:DC%2BD3sXpslems74%3DPubMed

108.

Villalon CM, Centurion D (2007) Cardiovascular responses produced by 5-hydroxytryptamine: a pharmacological update on the receptors/mechanisms involved and therapeutic implication. Naunyn Schmiedebergs Arch Pharmacol 376:45–63, 17703282, 1:CAS:528:DC%2BD2sXht1ygt7zK, 10.1007/s00210-007-0179-1PubMedCrossRef

Title: Serotonin and migraine: a reconsideration of the central theory
Author: Alessandro Panconesi
Publication date: 01-10-2008
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 5/2008
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1007/s10194-008-0058-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Serotonin and migraine: a reconsideration of the central theory

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2008

Locus of control moderates the relationship between headache pain and depression

Investigation of the immunoreactivities of NOS enzymes and the effect of sumatriptan in adolescent rats using an experimental model of migraine

An unusual form of TAC–TAC sine autonomic phenomena

Post-angiography headaches

Erratum to: Per-capita consumption of analgesics: a nine-country survey over 20 years

Trigeminal autonomic cephalalgias: frequency in a general neurology clinic setting